Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis

Abstract

Alpha-glucosidase inhibitors (AGIs) was reported to be associated with several rare adverse hepatic events, but with inconsistent results. We aimed to investigate the risk of hepatotoxicity associated with the use of AGIs in patients with type 2 diabetes mellitus (T2DM), and performed a systematic review and meta-analysis. Fourteen studies (n = 2881) were… (More)
DOI: 10.1038/srep32649

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Zhang2016AlphaglucosidaseIA, title={Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis}, author={Longhao Zhang and Qiyan Chen and Ling Li and Joey S. W. Kwong and Pengli Jia and Pujing Zhao and Wen Wang and Xu Zhou and Mingming Zhang and Xin Sun}, booktitle={Scientific reports}, year={2016} }